Ubs Group Ag Nuwellis, Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.56 - $2147.95 $8,986 - $34.5 Million	16,047 New	16,047 $9,000
Q2 2022 Aug 10, 2022	SELL	$0.48 - $1.12 $2,362 - $5,512	-4,922 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.85 - $1.27 $7,444 - $11,122	-8,758 Reduced 64.02%	4,922 $5,000
Q4 2021 Feb 14, 2022	BUY	$1.13 - $2.26 $14,413 - $28,826	12,755 Added 1378.92%	13,680 $16,000
Q3 2021 Nov 15, 2021	SELL	$2.12 - $4.6 $2,060 - $4,471	-972 Reduced 51.24%	925 $2,000
Q2 2021 Aug 13, 2021	BUY	$3.53 - $5.98 $6,696 - $11,344	1,897 New	1,897 $8,000

Ticker NUWE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,531,600
Market Cap $41.6M
Description
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.